Director/PDMR Shareholding

RNS Number : 7249K

GlaxoSmithKline PLC

20 April 2015

 

GlaxoSmithKline plc

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities (PDMR) and Connected Persons on 17 April 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1611.00 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $47.72 per ADS following the notional re-investment of the dividend paid to shareholders on 9 April 2015.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	19,261.141
Dr M M Slaoui		5,780.636
Mr S Dingemans	8,366.252
Mr R G Connor	3,751.573
Mr N Hirons	601.139	212.276
Mr S A Hussain	7,864.243
Mr W C Louv		1,695.701
Mr D S Redfern	2,852.896
Ms C Thomas	3,964.589
Mr P C Thomson	2,024.462
Mr D E Troy		3,596.168
Dr P J T Vallance	8,442.031
Ms E Walmsley	4,883.380
Mrs V A Whyte	532.249

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (connected person to Dr M M Slaoui)		93.510
Mrs K Thomson (connected person to Mr P C Thomson)	50.238

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

20 April 2015

 

END

 

 

RDSXBLFLEZFBBBB